| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033452 |
| Receipt No. | R000038127 |
| Official scientific title of the study | Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis |
| Date of disclosure of the study information | 2018/07/19 |
| Last modified on | 2018/07/19 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis | |
| Title of the study (Brief title) | Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis | |
| Region |
|
|
| Condition | ||
| Condition | Ulcerative colitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study is retrospectively compared the severity of histological inflammation with endoscopic findings in UC patients with mucosal healing (MH) in the remission maintenance phase, and investigated whether histological healing could be a predictor of sustained remission. |
| Basic objectives2 | Others |
| Basic objectives -Others | Clinical utility |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The primary endpoint of this study was to examine whether histological healing could be a predictor of sustained remission in ulcerative colitis patients with mucosal healing. |
| Key secondary outcomes | The second endpoint was to investigate the risk factors for relapse (age, sex, affected area, disease duration, and smoking rate). |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who had remained in clinical remission with only 5-aminosalicylic acid for at least 1 year without dose modification, who had been found to have mucosal healing by colonoscopy, and who had undergone a biopsy. | |||
| Key exclusion criteria | A case which the compliance rate is less than 80%.
A case using biologics agents. A case using immunomodulators. |
|||
| Target sample size | 166 | |||
| Research contact person | |
| Name of lead principal investigator | Mimari Kanazawa |
| Organization | Dokkyo Medical University |
| Division name | Department of Gastroenterology |
| Address | 880, Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan. |
| TEL | 0282872147 |
| mimari77@dikkyomed.ac.jp | |
| Public contact | |
| Name of contact person | Mimari Kanazawa |
| Organization | Dokkyo Medical University |
| Division name | Department of Gastroenterology |
| Address | 880, Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan. |
| TEL | 0282872147 |
| Homepage URL | |
| mimari77@dikkyomed.ac.jp | |
| Sponsor | |
| Institute | Dokkyo Medical University
Department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None. |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Red Cross Ashikaga Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | None. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038127 |